PINI, Luigi Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.208
EU - Europa 10.141
AS - Asia 8.080
SA - Sud America 1.109
AF - Africa 160
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
Totale 37.734
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.940
GB - Regno Unito 3.413
IT - Italia 3.121
CN - Cina 2.516
SG - Singapore 2.298
HK - Hong Kong 936
VN - Vietnam 869
BR - Brasile 838
SE - Svezia 707
DE - Germania 547
UA - Ucraina 487
FI - Finlandia 429
FR - Francia 408
RU - Federazione Russa 287
KR - Corea 279
TR - Turchia 274
BD - Bangladesh 250
NL - Olanda 223
BG - Bulgaria 170
CA - Canada 149
IN - India 148
ID - Indonesia 121
AR - Argentina 87
IE - Irlanda 75
MX - Messico 70
IQ - Iraq 50
JP - Giappone 49
EC - Ecuador 47
CO - Colombia 41
ZA - Sudafrica 41
ES - Italia 39
BE - Belgio 38
PK - Pakistan 36
AE - Emirati Arabi Uniti 35
CH - Svizzera 30
CL - Cile 30
PL - Polonia 29
AT - Austria 28
MA - Marocco 26
VE - Venezuela 25
IR - Iran 24
MY - Malesia 20
PH - Filippine 19
BY - Bielorussia 18
TN - Tunisia 18
NP - Nepal 16
UZ - Uzbekistan 16
DZ - Algeria 15
SA - Arabia Saudita 14
EU - Europa 13
PY - Paraguay 13
IL - Israele 12
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SN - Senegal 12
TH - Thailandia 12
EG - Egitto 11
KE - Kenya 10
NO - Norvegia 10
UY - Uruguay 10
AU - Australia 9
CR - Costa Rica 9
ET - Etiopia 9
JO - Giordania 9
LB - Libano 9
GE - Georgia 8
KZ - Kazakistan 8
PT - Portogallo 8
TW - Taiwan 7
AO - Angola 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
PA - Panama 6
RS - Serbia 6
YE - Yemen 6
AL - Albania 5
AZ - Azerbaigian 5
BH - Bahrain 5
GR - Grecia 5
NI - Nicaragua 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
DK - Danimarca 4
HU - Ungheria 4
PR - Porto Rico 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
EE - Estonia 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
Totale 37.695
Salva come PNG Salva come JPEG
Città #
Southend 2.672
Ashburn 1.722
Fairfield 1.719
Santa Clara 1.713
Singapore 1.412
Woodbridge 1.392
Jacksonville 1.009
Houston 970
Hefei 922
Hong Kong 914
Chandler 798
Dearborn 640
Wilmington 635
Seattle 596
Cambridge 573
Ann Arbor 561
Beijing 463
London 393
Nyköping 361
San Jose 356
Milan 295
Los Angeles 284
Chicago 281
Helsinki 272
Ho Chi Minh City 272
Seoul 261
Council Bluffs 257
The Dalles 256
Hanoi 216
Modena 200
Princeton 198
San Diego 175
New York 167
Sofia 166
Eugene 162
Rome 161
Lauterbourg 148
Izmir 142
Buffalo 138
Dallas 116
Moscow 105
Salt Lake City 87
Jakarta 78
Turin 72
Shanghai 71
Redwood City 69
Des Moines 68
Dublin 68
Naples 68
Bologna 63
São Paulo 62
Orem 59
Tokyo 43
Palermo 41
Toronto 41
Columbus 40
Genoa 39
Haiphong 39
Florence 38
Tampa 38
Da Nang 37
Elk Grove Village 37
Nanjing 37
Rio de Janeiro 37
Brussels 35
Frankfurt am Main 35
Verona 35
Brooklyn 34
Phoenix 34
Brescia 33
Dong Ket 33
Ottawa 32
Atlanta 29
Bianco 29
Boardman 29
Norwalk 29
Bremen 28
Paris 28
Falkenstein 27
Guangzhou 27
Lancaster 27
Catania 26
Chennai 26
Falls Church 26
Miami 26
Munich 26
Mexico City 25
Miano 25
Parma 23
Sterling 22
Montreal 21
Perugia 21
Tulare 21
Baghdad 20
Denver 20
Fremont 20
Jinan 20
Philadelphia 20
Warsaw 20
Johannesburg 19
Totale 26.276
Salva come PNG Salva come JPEG
Nome #
La flunarizina nella profilassi delel crisi emicraniche delle cefalee cclassiche e comuni 2.193
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. 786
OPPIACEI: FARMACOCINETICA, DIPENDENZA, DETOSSIFICAZIONE, TRATTAMENTI AGONISTI ED ANTAGONISTI 411
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 396
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 368
A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants 365
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 360
Basal cutaneous pain threshold in headache patients 360
Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol 356
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 341
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 340
Endocannabinoids in chronic migraine: CSF findings suggest a system failure 320
BRAIN-SEROTONIN BINDING-CAPACITY, ANALGESIA AND DRUG SERUM LEVELS AFTER ACUTE TREATMENT WITH PHENAZONE IN RATS 314
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 310
Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes 309
A case-control study of visually evoked postural responses in childhood with primary headaches 309
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 308
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis 304
A preliminary study on the relationship between central auditory processing and childhood primary headaches in the intercritical phase 302
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 302
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 300
Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test 286
Diamo parole al dolore. La percezione del disagio e della difficoltà nella vita quotidiana delle bambine e dei bambini 285
NF-kappa B activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks 284
Italian guidelines for primary headaches: 2012 revised version. 278
Effect of rofecoxib on nociception and the serotonin system in the rat brain 276
Valutazione del contenuto plasmatico e possibile uso terapeutico del glutatione in pazienti con cefalea cronica quotidiana ed uso giornaliero di associazioni analgesiche 275
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study 275
A case of a GH-producing pituitary adenoma associated with a unilateral headache with autonomic signs 274
Anti-epileptic drugs in the preventive treatment of migraine headache : a brief review. 272
O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache 272
Disposition of naproxen after oral administration during and between migraine attacks. 269
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 269
Long-term follow-up of patients treated for chronic headache with analgesic overuse 268
HIGH EFFICACY AND LOW-FREQUENCY OF HEADACHE RECURRENCE AFTER ORAL SUMATRIPTAN 265
Headaches associated with chronic use of analgesics: A therapeutic approach 264
Acetylsalicyclic acid potentiates the antinociceptive effect of morphine in the rat:involvement of the central serotonergic system. 263
A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse 256
THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE 256
PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION 253
Effects of chronic treatment with phenazone on the hot plate test and [3H]-Serotonin binding sites in pons and cortex membranes of the rat 252
Effect of acetylsalicylic acid on formalin test and on serotonin system in the rat brain. 252
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 250
The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain 249
Analgesic abuse in chronic headache sufferers 249
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial. 249
Lack of activity of Ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats 248
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 248
INTERNATIONAL-HEADACHE-SOCIETY CLASSIFICATION - INTEROBSERVER RELIABILITY IN THE DIAGNOSIS OF PRIMARY HEADACHES 245
Phenytoin-Treatment Of Rdeb Vegetans 245
An unusual case report on the possible role of Warfarin in migraine prophylaxis 245
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 244
The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain. 242
INFLUENCE OF PROLONGED THERAPY WITH FLUNARIZINE ON GLUCOSE, INSULIN AND C-PEPTIDE METABOLISM 241
Lack of association between five serotonin metabolism-relatedgenes and medication overuse headache. 239
Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid 237
Risk-benefit and cost-benefit ratio in headache treatment 236
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 233
The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat 233
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium 232
The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain 232
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 229
Nimodipine in otolaryngology: from past evidence to clinical perspectives 228
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 228
An emerging problem in clinical practice: how to treat chronic headache patients. 225
Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: the results of a pilot study. 224
CHRNA5 polymorphism and nicotine dependence in patients with cluster headache 223
Plasma glutathione level in chronic headache drug abuser patients 222
The effect of Paracetamol on nociception and dynorphin A levels in the rat brain 222
Triptans: the experience of a clinical pharmacologist in clinical practice. 219
Chronic daily headache: how to manage it? 219
Relevance of analgesic abuse in the maintenance of chronic headaches 218
Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat 218
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 218
Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders 217
Different characteristics of triptans 217
Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration 216
Analysis on the use of migraine preventative drugs in current clinical practice 215
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels 215
Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse 214
Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients - 213
Pharmacokinetics of tia profenic acid in headache attacks - a preliminary report 213
Homocysteine levels and cardiovascular disease in migraine with aura 213
High prevalence of patent foramen ovale in migraine with aura 211
Tacrolimus pharmacokinetics in kidney transplant recipients. 210
DOES CHRONIC USE OF SUMATRIPTAN INDUCE DEPENDENCE 209
Ambiti e limiti delle prescrizioni farmaceutiche nell'esercizio dell'odontoiatria e protesi dentaria 208
Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study 208
Active reporting scheme: an example to evaluate specific adverse drug reactions. 206
Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. A comment. 205
Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey 205
Naloxone-reverisble antinociception by paracetamol in the rat. 204
Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial 203
Topo-kinesthetic memory in chronic headaches. A new test for chronic patients: preliminary report 203
Increased levels of Neurotrophins are not specific for chronic migraine: Evidence from primary fibromyalgia syndrome 201
Urinary neopterin in malignant lymphoma 201
PHARMACOKINETICS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS 200
Circadian variations of proopiocortin-related peptides in children with migraine. 199
A CB1 agonist in the treatment of medication-overuse headache: a possible therapeutic strategy 199
PHARMACOKINETICS OF NAPROXEN AFTER ORAL-ADMINISTRATION DURING AND OUT OF MIGRAINE ATTACKS 198
Totale 27.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 0 0 168
2021/20222.935 92 450 319 326 66 75 194 139 279 198 443 354
2022/20232.399 308 231 141 208 268 363 49 213 300 51 120 147
2023/20242.231 116 143 158 171 370 166 200 268 93 83 223 240
2024/20256.336 282 117 155 473 1.230 883 341 311 840 467 595 642
2025/202610.878 716 540 1.207 1.289 1.331 822 1.203 664 1.084 947 826 249
Totale 37.840